TRUMPF and iThera introduce imaging for healthcare
Summary
This VCSEL-based subsystem can replace current photonic systems and is a game changer for routine clinical use, beginning with soft tissue perfusion and oxygenation measurements, applicable to a wide range of diseases. The VCSEL technology, with its benefits like precision, compact structure, energy efficiency and wide range of wavelengths is perfect for this application,” said Alexander Weigl, Head of Product Management at TRUMPF Photonic Components. “At TRUMPF Photonic Components, we view the medical technology and life sciences sector as a growth area for numerous VCSEL wavelengths and applications." “Using VCSELs will allow us to cut light-source-related costs, volume and power consumption of our market-leading optoacoustic imaging devices by a factor of 100,” explained Patrick Leisching, CTO at iThera Medical. The photonic subsystem presented is based on a compact set-up of high power VCSEL arrays and bare ToF CMOS driver chips.